BDKRB1 and infection: The findings that R-954 reduced mortality indexes, inhibited chronic myocarditis, and ameliorated disturbances in heart impulse conduction during the late stage of infection suggest that severity of chronic chagasic cardiomyopathy may be attenuated via pharmacological targeting of the KKS/B1R pathway.